`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NEPTUNE GENERICS, LLC
`Petitioner
`
`
`v.
`
`
`CORCEPT THERAPEUTICS, INC.
`Patent Owner
`
`________
`
`Patent No. 8,921,348
`Issued: December 30, 2014
`Filed: October 29, 2013
`Inventor: Joseph K. Belanoff
`Title: “Optimizing mifepristone levels in plasma serum of patients suffering from
`mental disorders treatable with glucocorticoid receptor antagonists”
`____________________
`
`Inter Partes Review No.—not yet assigned
`
`
`
`
`__________________
`
`
`NEPTUNE GENERICS, LLC’S POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`Additionally, Petitioner designates lead counsel:
`
`Kenneth M. Goldman (Reg. No. 34,174)
`MASSEY & GAIL LLC
`50 E. Washington Street, Suite 400
`Chicago, Illinois 60602
`310.283.1590 (reception)
`kgoldman@masseygail.com
`
`phone: 510.507.1249
`
`For: NEPTUNE GENERIC S, LLC
`Signature: ?§§ 2 8W C/
`3,, @ euzmzh O'wmcé/
`————____________
`Title:
`CF13
`
`
`Beam
`
`